Parisi Gray Wealth Management Has $1.74 Million Stake in UnitedHealth Group Incorporated $UNH

Parisi Gray Wealth Management trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,576 shares of the healthcare conglomerate’s stock after selling 534 shares during the period. Parisi Gray Wealth Management’s holdings in UnitedHealth Group were worth $1,740,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management bought a new position in UnitedHealth Group during the 4th quarter worth $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group during the 1st quarter worth $42,000. Finally, Investment Management Corp VA ADV bought a new position in UnitedHealth Group during the 4th quarter worth $44,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.3%

Shares of NYSE:UNH opened at $352.61 on Monday. The company has a market capitalization of $319.35 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.30 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business’s 50-day moving average is $291.98 and its 200-day moving average is $368.31. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. HSBC reiterated a “reduce” rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Bank of America lifted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research note on Monday, August 18th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.